Pear TherapeuticsPEARQ
13F holders, Q1 2024 (March 31)1holders
$0.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Pear Therapeutics Inc. (PEARQ) in their 13F filings. The largest holder was Roble, Belko & Company, Inc ($0).
- Company
- Pear Therapeutics Inc.
- CUSIP
- 704723105
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Roble, Belko & Company, Inc | 0.00% | No change | 4,502 | $0 |
"% of holder's portfolio" is PEARQ's weight in each manager's 13F, not the share of Pear Therapeutics Inc. the manager owns.